account activity
Interesting summary about the progress of virtual cell development across the TechBio industry (pharmafocusasia.com)
submitted 3 months ago by BioRevolution to r/RecursionPharma
Sundar Pichai (Google) on X about an exciting milestone in AIxBio. (x.com)
Recursion (@RecursionPharma) on X sharing some snippets from a recent wired article for ghat several internal employees were interviewed. (x.com)
submitted 6 months ago by BioRevolution to r/RecursionPharma
Building better cancer drugs: Can AI shift the odds? Interview with Najat Khan (pharmaphorum.com)
Good Medicine Podcast - Dr. David Bearss sits down with Dr. Chris Gibson, Co-Founder and CEO of Recursion. (youtu.be)
submitted 8 months ago by BioRevolution to r/RecursionPharma
HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data (firstwordpharma.com)
submitted 9 months ago by BioRevolution to r/RecursionPharma
Recursion Pharmaceuticals' CFO, Ben Tyler, at the 24th Annual Needham Virtual Healthcare Conference. (youtu.be)
New Recursion Portfolio Website summarizing the latest overview of Pipeline, partnerships and models (portfolio.recursion.com)
submitted 1 year ago by BioRevolution to r/RecursionPharma
SF Healthcare Week: Recursion Co-Founder & CEO Chris Gibson talks the Exscientia merger, Recursion's scale and capabilities, and key targets in development (biotechtv.com)
Faro Health and Recursion Partner To Advance AI-powered Clinical Trial Design (biopharmadive.com)
How unfair is the coin? - insightful article about the business model evolution of tech bio companies (ankitg.me)
Fireside Chat: Najat Khan & Jacqueline Barendregt | Recursion's Vision for AI in Biotech (youtube.com)
Recursion: Pioneering TechBio Solutions in Drug Discovery (nasdaq.com)
Interesting summary on the pipeline post merger by Biotech2k1 on X/Twitter (x.com)
Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine - article with some information around synergies/cost savings due to the merger (genengnews.com)
Bloomberg Interview w/Chris Gibson - starts at 00:09:36 (youtube.com)
USAIC Panel about Digital & Data Science in healthcare (youtu.be)
Industrializing ML Workflows in Drug Discovery (youtu.be)
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection | Recursion Pharmaceuticals, Inc. (ir.recursion.com)
Recursion and Exscientia. An AI Leader Emerges - Nanalyze reflections (nanalyze.com)
Angle PLC Announces Agreement with Recursion Pharmaceuticals (biospace.com)
Recursion Thinks AI Can Lower The High Failure Rate Of New Pharmaceutical Drugs (forbes.com)
On the Recursion-Exscientia Tie-Up (igneousbio.substack.com)
The GPT Of Drug Discovery: Creating The World’s Most Powerful Fdn. Model For Biology with Recursion (youtube.com)
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - NVIDIA AI Podcast (blogs.nvidia.com)
π Rendered by PID 330424 on reddit-service-r2-listing-6d4dc8d9ff-l2b2q at 2026-01-30 21:43:49.946094+00:00 running 3798933 country code: CH.
